Guang-Liang Hong Selected Research

Interleukin-10 (Interleukin 10)

10/2018	Partial Depletion of Regulatory T Cells Enhances Host Inflammatory Response Against Acute Pseudomonas aeruginosa Infection After Sepsis.
11/2017	Ethyl pyruvate reverses development of Pseudomonas aeruginosa pneumonia during sepsis-induced immunosuppression.
9/2008	[Changes of toll-like receptor, TNF-alpha and IL-10 in liver tissue of rats before and after intragastric infusion with alcohol with vibrio vulnificus sepsis].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guang-Liang Hong Research Topics

Disease

6	Sepsis (Septicemia) 01/2022 - 09/2008
4	Poisoning 01/2022 - 04/2010
4	Lung Injury 01/2022 - 01/2011
2	Critical Illness (Critically Ill) 01/2021 - 01/2020
2	Infections 10/2018 - 01/2011
2	Hemorrhage 05/2014 - 04/2010
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2023
1	Pancreatitis 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Burns 11/2017
1	Pneumonia (Pneumonitis) 11/2017
1	Starvation 01/2017
1	Coinfection 12/2016
1	Multiple Organ Failure (MODS) 03/2016
1	Septic Shock (Toxic Shock Syndrome) 05/2014
1	Wounds and Injuries (Trauma) 03/2012
1	Aspergillosis 07/2011
1	Muscle Cramp (Cramp) 04/2010
1	Dyspnea (Shortness of Breath) 04/2010
1	Acute Lung Injury 04/2010
1	Pulmonary Edema 04/2010
1	Liver Diseases (Liver Disease) 01/2009

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2009
3	Interleukin-10 (Interleukin 10)IBA 10/2018 - 09/2008
3	ParaquatIBA 04/2016 - 04/2010
3	Messenger RNA (mRNA)IBA 01/2012 - 01/2009
2	AlbuminsIBA 01/2023 - 01/2022
2	HMGB1 Protein (HMG1)IBA 11/2017 - 01/2011
2	Lactic Acid (Lactate)FDA LinkGeneric 03/2016 - 05/2014
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2009 - 09/2008
2	Anti-Infective Agents (Microbicides)IBA 01/2009 - 09/2008
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	PotassiumIBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2021
1	Furosemide (Lasix)FDA LinkGeneric 01/2020
1	ethyl pyruvateIBA 11/2017
1	Tetradecanoylphorbol AcetateIBA 01/2017
1	IonomycinIBA 01/2017
1	Sirolimus (Rapamycin)FDA Link 01/2017
1	Sirtuin 1IBA 04/2016
1	NF-E2-Related Factor 2IBA 04/2016
1	AntioxidantsIBA 04/2016
1	Tight Junction ProteinsIBA 03/2016
1	Dopamine (Intropin)FDA LinkGeneric 05/2014
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2014
1	CytokinesIBA 01/2011
1	SodiumIBA 04/2010
1	Angiotensin-Converting Enzyme 2IBA 04/2010
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2010
1	Unithiol (DMPS)IBA 04/2010
1	Levofloxacin (Levaquin)FDA Link 01/2009
1	Cefoperazone (Cefoperazone Sodium)FDA Link 01/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2008
1	N 30IBA 09/2008

Therapy/Procedure

2	Ligation 10/2018 - 11/2017
2	Punctures 10/2018 - 11/2017
2	Debridement 05/2014 - 03/2012
2	Subcutaneous Injections 01/2011 - 01/2009
1	Critical Care (Surgical Intensive Care) 01/2020
1	Length of Stay 12/2016
1	Therapeutics 04/2016
1	Conduction Anesthesia (Regional Anesthesia) 05/2014
1	Surgical Amputation (Amputations) 03/2012
1	Intraperitoneal Injections 01/2009